Breast Cancer (Therapy)
FDA Reviews Breast Cancer Therapies
Published in Women's Health Weekly, September 7th, 1998
On September 2, 1998, advisers to the U.S. Food and Drug Administration (FDA) met to sort out the controversy in recommending whether the FDA should approve tamoxifen as the first pill to prevent breast cancer. In another major development, the panel also will recommend whether the FDA should approve Herceptin to treat advanced breast cancer, the first in a wave of promising gene-based cancer treatments.
The FDA is expected to make final decisions on both drugs by November 1998, but it typically follows its advisers' recommendations.
The drug, tamoxifen, made headlines earlier this year when the National Cancer Institute (NCI) declared it could help...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
New Genetic Mutation Discovered With Link to Breast Cancer - Breast Cancer (Diagnostics)
Ultrasound-Aided Breast Biopsy Avoids Many Surgical Biopsies - Breast Cancer (Education)
"Hotbed of Misinformation" Causes Confusion - Breast Cancer (Therapy)
Snake Venom Slows Tumor Growth - Cancer (Diagnostics)
Elevated Acid Plasma Levels May Signal Gynecological Cancer - Cardiovascular Disease (Diagnostics)
Levels of C-Reactive Protein May Predict Heart Attack and Stroke - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
